Biomedical industry is China's strategic emerging industry, with the aging intensification, consumption level continues to upgrade, China's biomedical industry has developed rapidly
.
At the same time, the market demand for related pharmaceutical equipment is also expanding
.
It is worth noting that pharmaceutical equipment has always been an important part of the biopharmaceutical industry chain, and at present, the country and many places are constantly issuing favorable documents to stimulate local innovation
of key biopharmaceutical consumables and equipment.
The development of the biomedical industry is accelerating, stimulating local innovation in pharmaceutical equipment (Image source: Pharmaceutical Network)
For example, recently, the Shanghai Municipal Science and Technology Commission, the Municipal Economic Information Commission, and the Municipal Health Commission jointly issued the "Shanghai Action Plan for Promoting Cell Therapy Science and Technology Innovation and Industrial Development (2022-2024)
".
The Action Plan clarifies the target plan
for the scale of Shanghai's cell therapy industry to reach 10 billion yuan from 2022 to 2024.
At the same time, under the goal of 10 billion yuan, the Action Plan also puts forward clear tasks for the industrial chain: accelerate the research and development of core equipment and materials, including automated closed cell processing equipment, process analysis technology systems, functional identification reagents, cell culture media, virus purification chromatography fillers, etc.
; and accelerate the localization of
key equipment and materials such as high-end biological reagents, biological raw materials, virus vectors, culture systems, testing equipment, and production equipment.
In this regard, the industry believes that the policy will drive Shanghai's local disposable bioprocess service providers and related equipment manufacturers to usher in a new round of high-quality development
.
In fact, in recent years, with the rapid development of China's biopharmaceutical industry, the continuous approval of related biopharmaceutical products, and the gradual transfer of global biopharmaceutical CDMO production capacity to China, the market demand for biopharmaceutical equipment in China is expanding, and the localization demand for upstream key equipment and consumables has become very urgent
.
A relevant person in charge of a pharmaceutical company has said that taking the "bag of cultured cells" as an example, it needs to be imported
for a long time.
It is reported that the "bag" required by biopharmaceutical companies is one of the
key upstream consumables.
The consumables, systems and equipment used for cell culture mainly include disposable sampling bags, storage\liquid bags, stirring bags, cryopreservation bags, disposable culture flasks, centrifuge bottles\bags, disposable bioreactors, tangential flow ultrafiltration systems, capsule sterilization grade filters, etc
.
In these applications, bioprocessing films are one of the key building blocks, and their core technology has long been in the hands of
European and American giants.
In addition, from the perspective of the current situation of industry development, the domestic pharmaceutical equipment market, especially high-end pharmaceutical machines, has long relied on imported manufacturers, and domestic pharmaceutical machinery enterprises have little
right to speak.
However, in recent years, as local enterprises continue to increase investment in innovation and R&D, as well as domestic substitution brought about by the epidemic, the entire domestic pharmaceutical equipment industry has gradually accelerated its transformation and upgrading
from low-end to high-end.
At present, many subdivisions have also broken the monopoly of foreign capital, such as a company with disposable liquid storage bags, disposable process system equipment, disposable bioreactors, filtration products, etc.
, complete product pipeline, and can provide overall technical solutions
.
Among them, the disposable cryophil bag is very suitable for the current demand for pharmaceutical consumables in the field of biopharmaceuticals, especially in the current hot field of cell therapy, with its advantages of low temperature tolerance, safety
, stability and high biocompatibility.
In the first half of this year, the "14th Five-Year Plan" for the development of the bioeconomy issued by China made it clear that it is necessary to focus on improving the people's health security capacity, focusing on drugs, vaccines, advanced diagnosis and treatment technology and equipment, biomedical materials, precision medicine, testing and biological health care, etc.
, to enhance the original innovation ability, strengthen drug regulatory scientific research, and enhance the supply chain guarantee level
of biomedical high-end products and equipment 。 In this regard, analysts believe that with the continuous promotion of many favorable policies and documents, it is undoubtedly expected to bring more opportunities to the leading enterprises with strength in the biomedical equipment industry, and promote the acceleration
of local innovation of biopharmaceutical consumables and equipment in China.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
